Methods enabling prion replication ex vivo are important for advancing prion studies. However, few such technologies exist, and many prion strains are not amenable to them. Here we describe a prion organotypic slice culture assay (POSCA) that allows prion amplification and titration ex vivo under conditions that closely resemble intracerebral infection. Thirty-five days after contact with prions, mouse cerebellar slices had amplified the abnormal isoform of prion protein, PrP Sc , >10 5 -fold. This is quantitatively similar to amplification in vivo, but fivefold faster. PrP Sc accumulated predominantly in the molecular layer, as in infected mice. The POSCA detected replication of prion strains from disparate sources, including bovines and ovines, with variable detection efficiency. Pharmacogenetic ablation of microglia from POSCA slices led to a 15-fold increase in prion titers and PrP Sc concentrations over those in microglia-containing slices, as well as an increase in susceptibility to infection. This suggests that the extensive microglial activation accompanying prion diseases represents an efficacious defensive reaction.
The defining trait of transmissible spongiform encephalopathies (TSEs) is transmissibility between individuals or across species 1 . The infectious agent causing TSEs is the prion, which may be identical to PrP Sc , a partially protease-resistant isoform of a membrane glycoprotein termed PrP C . Mice devoid of the Prnp gene, which encodes PrP C , resist prion infections 2 .
To determine prion titers, endpoint dilutions of samples are inoculated into large numbers of indicator animals. The incubation time of prion infections is negatively correlated to the size of the inoculum, allowing a simplified incubation time bioassay that sacrifices precision, yet requires fewer animals 3 . Because small amounts of infectivity correlate with incubation times, the observation periods span the life of indicator animals. This is impractical and expensive. Minimizing the numbers of animals used for titration would also reduce the suffering wrought by prion infections.
The scrapie cell assay in endpoint format (SCEPA) eliminates some of the above concerns and allows dramatically faster assays 4 . Here, cells are exposed to endpoint titrations of prions and subsequently passaged several times. Prion titers are determined by counting PrP Sc -positive tissue-culture wells. The SCEPA is equivalent to animal bioassays in that it detects actual transfer of prion infectivity from samples to susceptible cells. However, the reactions of the CNS to prion infection include highly diverse cell types such as neurons, astrocytes, oligodendrocytes and microglia acting in concert. This diversity cannot be reproduced in the SCEPA, which is based on monoclonal, homogeneous cells. Also, the range of cell lines that have been identified as susceptible to prion infection in vitro is limited 5 . At present this restricts the applicability of the SCEPA to a subset of mouse-adapted prion strains. These two limitations may be interdependent, as the machinery necessary for overcoming strain and species barriers may require cells distinct from those that replicate prions. Hence any infectivity titrations of prion variants that do not efficiently infect cultured cells still require animal bioassays.
Here we show that chronically cultured organotypic cerebellar slices rapidly amplify PrP Sc after exposure to prions, thereby circumventing some of the above limitations. This protocol allows dissection of CNS pathologies in a complex cellular environment morphologically similar to the intact brain. The sensitivity of the prion organotypic slice culture assay (POSCA) was marginally lower than that of the SCEPA. Although the POSCA makes use of animals as the original tissue donors, many genetically identical slices can be produced from each individual mouse. Hence genetic background variation-which may account for the variability of mouse bioassays-can be controlled by comparing samples prepared from the same individual mouse.
Activation of microglia in prion infections is very extensive and precedes neurodegeneration 6, 7 . Microglia are abundantly associated with prion plaques, and PrP Sc can sometimes be found within microglia 6, 8 . However, it is unclear whether microglial activation represents a precipitating or a defensive reaction. Using the POSCA we found that microglial ablation from slices from CD11b-HSVTK transgenic mice markedly increased prion titers and PrP Sc deposition. Thus microglia may be important in containing prion loads during the course of prion infections.
RESULTS
Longevity of mouse cerebellar slices in long-term cultures As prion infections progress extremely slowly in vivo, we reasoned that slice infection would require organotypic cultures of great longevity. We tested various parameters, including the method used for preparing slices, age of the mice, culture medium composition, and volume and frequency of media changes (data not shown). We achieved the best results when preparing slices by vibratome sectioning and culturing them on Millicell-CM polytetrafluoroethylene membranes, exchanging the full volume of medium thrice each week.
We assessed slice viability after 5 weeks of culture by morphometric quantitation of cells permeable to propidium iodide (PI) and by DEVDase activity assays, which measure the prevalence of dead cells and the substrate turnover rate of executioner caspases, respectively. Control slices were treated with staurosporine, which induces widespread apoptosis ( Supplementary Fig. 1a-c online) . Untreated slices showed 0.1% ± 0.02% (mean ± s.d.) of PI + cells (or o0.1% ± 0.02% of the total tissue surface area) and 2.1% ± 0.6% of DEVDase levels seen in staurosporine-treated slices. Hence, slices were viable for up to 5 weeks. Morphological and immunohistochemical analyses with various markers of CNS constituents ( Supplementary Fig. 1d-h ) supported this conclusion.
The POSCA assay Most TSE assays rely on the differential susceptibility of PrP C and PrP Sc to digestion with proteinase K (PK) 9 . The relative resistance of PrP Sc to PK depends on the prion strain and the composition of non-PrP contaminants within the samples. We therefore determined the minimal conditions under which all PrP C present in 5-week-old slices is fully degraded by PK ( Supplementary Fig. 2a online) . We found that digestion of 20 mg protein lysate with 25 mg ml -1 PK (in a reaction volume of 20 ml, corresponding to 1 mg ml -1 total protein) ensured complete, reproducible removal of PrP C . We used these conditions in all subsequent experiments.
In a first attempt, we prepared slices from prion-inoculated pups, but after 5 weeks ex vivo, we found no PrP Sc in the slices ( Supplementary   Fig. 2b ). Next, we prepared slices from 10-d-old PrP C -overexpressing tga20 TK (offspring of tga20 +/+ males crossed to CD11b-HSVTK females 10 ) pups or from Prnp o/o (mice devoid of PrP C ) pups 11 and incubated groups of ten slices with 1 ml of buffer containing 20 mg 'RML' (Rocky Mountain Laboratory strain) inoculum, consisting of crude brain homogenate from pooled, terminally ill wild-type mice on a CD1 background infected with sixth-passage RML prions. To minimize any toxicity from cellular debris, slices were exposed to RML for 1 h at 4 1C in the presence of kynurenic acid.
After 5 weeks, we analyzed slices by western blotting (Fig. 1a) . In all experiments, we used monoclonal antibody POM1 (ref. 12) to detect PrP. To facilitate comparisons, we loaded 20 mg protein from the brain of a C57BL/6 mouse terminally ill with scrapie next to the marker on each blot. In lysates of RML-infected tga20 TK cultures, we observed a characteristic triplet band pattern representing di-, mono-and unglycosylated forms of PrP Sc after treatment with 25 or 50 mg ml -1 PK (Fig. 1a) . RML-exposed Prnp o/o slices and slices exposed to uninfected brain homogenate never showed any PK-resistant material (Fig. 1a) .
Operating performance of the POSCA The PrP Sc signal observed in POSCA slices might partly represent residual inoculum adhering to slices. We therefore performed titration experiments using varying amounts of inoculum for the infection of slices. PrP Sc was unambiguously detected in tga20 TK slices exposed to as little as 1 mg RML homogenate (Fig. 1b) . The amount of PrP Sc recovered after 5 weeks was Z40-fold higher than the total inoculum used to infect the cultures ( Supplementary Fig. 3 online) . Hence all PrP signals resulted from bona fide slice infection and de novo PrP Sc amplification within slices. In RML-treated Prnp o/o cultures (n ¼ 5) or in cultures treated with uninfected brain homogenates (n ¼ 5), we never observed PK-resistant material, even in slices exposed to 10 mg of RML (Fig. 1b) , indicating that PrP Sc was amplified at least 10 4 -fold. Slices infected with small amounts of RML showed less PrP Sc than those infected with larger amounts (Fig. 1b) . This correlation was not explainable by variations in PrP C expression ( Supplementary Fig. 4a online), and it suggests that PrP Sc was accumulating exponentially at the time of analysis. We recorded PrP Sc amplification within slices over time (Fig. 1c) . One hour after inoculation we detected no residual inoculum (Fig. 1c) , and 14 d after inoculation (dpi) we observed no indication of prion replication. After 21 d we observed a definite PrP Sc signal (Fig. 1c) . PrP C expression was similar in all cultures (Supplementary Fig. 4b ).
We then examined the impact of host PrP C expression levels on prion replication. We infected cultures from tga20 TK mice (heterozygous Prnp +/o mice carrying one copy of the tga20 transgene), Prnp +/o mice, or tga20 + mice (mice carrying one copy of the tga20 transgene), and compared PrP Sc amounts. We observed a positive correlation between host expression of PrP C (tga20 TK 4 tga20 + 4 Prnp +/o ; Supplementary Fig. 4c ) and the amount of PrP Sc observed in the cultures 5 weeks after inoculation (tga20 TK 4 tga20 + 4 Prnp +/o ; Fig. 1d ), as has been seen after intracerebral inoculation of mice 13 .
Infectivity amplification and relative sensitivity of POSCA We then tested whether deposition of PrP Sc accompanies prion replication, defined as increase in prion infectivity. Samples from the experiment in Figure 1c were used to infect the PK1 subclone 4 of N2a neuroblastoma cells. Tga20 TK culture homogenates showed no infectivity when assayed o28 d after exposure to RML. Slices assayed at 28 and 35 d contained 46.8 log TCI 50 (tissue culture infectivity) units of prion infectivity per gram total protein (1 TCI 50 unit being the dose required to infect 50% of PK1 culture wells) as determined by SCEPA 4 (Fig. 1e) . We detected no infectivity in RML-exposed Prnp o/o sliceculture lysates at any time. We compared the amount of infectivity in POSCA slices to a calibration curve of RML (Fig. 1e) . RML contained 46.8 log TCI 50 units g -1 protein (1 g RML homogenate contained 138 mg protein), similar to the amount of infectivity measured in RMLinfected slices. Therefore, both PrP Sc and prions were amplified in slices to amounts similar to those detected in terminally ill mouse brains.
To determine the dose required to infect 50% of the slice cultures (slice culture infectivity; SCI 50 ), we performed an endpoint dilution experiment. We found that all slices infected with 1 mg RML, yet none of the cultures infected with 0.1 mg RML, accumulated PrP Sc ( Table 1 , Supplementary Fig. 5a online and data not shown). The SCI 50 was calculated according to standard methods 14 . Accordingly, RML homogenate contained 46.7 ± 0.1 log SCI 50 g -1 . To compare the sensitivity of the POSCA with that of other bioassays, we measured the titers of serially diluted RML homogenate by intracerebral inoculation into tga20 and CD1 mice as well as by SCEPA ( Table 1) . The tga20 bioassay measured 9.9 ± 0.2 log ID 50 units (1 ID 50 unit being the amount of infectivity that will cause infection in 50% of experimentally infected animals) and CD1 mice 9.3 ± 0.9 log ID 50 units per gram of brain homogenate. In comparison, the SCEPA showed a sensitivity of 7.7 ± 0.5 log ID 50 g -1 ( Table 1) .
Infected slices appear healthy
We assessed the morphological integrity of slices by immunohistochemistry 1, 7, 21 and 35 dpi. Neurons (calbindin), astrocytes (glial fibrillary acidic protein (GFAP)) and myelin (myelin basic protein (MBP)) appeared intact. A progressive broadening of cell layers became evident at 7-35 d of culture ( Supplementary Fig. 1d-f ). Microglia and macrophages increased over time, confirming that slices underwent progressive microgliosis ( Supplementary Fig. 1g ,h). No difference was detected between tga20 TK cultures treated with uninfected brain homogenates or RML-treated Prnp o/o and tga20 TK cultures at any time point ( Supplementary Fig. 1d-h) .
Unexpectedly, prion infection did not affect viability 5 weeks after prion infection (one-way analysis of variance (ANOVA) with Bonferroni multiple comparison test, P 4 0.05, n ¼ 12; Fig. 2a,b) . We evaluated the localization of PrP Sc replication and deposition using the histoblot technique 15 . We observed a strong PrP Sc signal in the molecular and Purkinje cell layers, suggesting substantial PrP Sc deposition in granule cell axons, Purkinje neurons and possibly astrocytes (Fig. 2c ). An intermediate signal was observed in the granule cell layer, and a weak signal was present in the white matter.
The POSCA is applicable to a broad range of prion strains We exposed tga20 +/+ slices to 100 mg of brain homogenate from mouseadapted prion strains originally derived from scrapie-infected sheep, cows infected with bovine spongiform encephalopathy (BSE), or deer infected with chronic wasting disease (CWD) and analyzed PrP Sc 5 weeks after inoculation (see Supplementary Table 1 online) . Mouse-adapted scrapie strains 79A and 139A, which replicate in PK1 The assay sensitivity of the tga20 and CD1 bioassay, SCEPA and POSCA, compared by performing endpoint titrations of the same batch of RML brain homogenate in the various assays. The infectivity titers per gram of brain were determined according to ref. 14 and expressed as TCI 50 units for the SCEPA, SCI 50 for the POSCA, and LD 50 for tga20 and CD1 mice upon intracerebral inoculation. Each data point represents the number of infected animals or cultures out by the total number of animals or cultures exposed to the inoculum. The sensitivity of POSCA lags behind that of SCEPA by 1 log, but is considerably enhanced by microglial depletion.
a Microglia-depleted slices.
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cells (data not shown), led to an accumulation of PrP Sc comparable to or higher than that in RML-exposed slices (Fig. 3a) . The mouse-adapted BSE strain 301C and, to a lesser extent, three scrapie isolates passaged once (5114/2) or twice in tga20 (5193/1) or wildtype mice (5192/2) also replicated in slices ( Supplementary Fig. 5b and data not shown). PK1 cells are known to be resistant to infection with the mouse scrapie strain ME7 (ref. 4). In slices exposed to 100 mg ME7, we found only a faint PrP Sc signal (Fig. 3b) , but 1 mg of ME7 inoculum clearly induced PrP Sc in all cultures (Fig. 3b) . Not all scrapie strains tested positive in the POSCA, and there was a correlation between short incubation times in vivo after intracerebral inoculation and the ability to replicate in the POSCA ( Supplementary Fig. 5 and Supplementary Table 1) . We also tested mouse-adapted CWD strains from a Colorado mule-deer herd 16 . Mouse-adapted CWD inoculum did not seem to replicate in tga20 slices, irrespective of in vivo incubation times (data not shown and Supplementary Table 1) .
Conditional microglial depletion in organotypic slices
CD11b-HSVTK mice allow conditional ablation of microglia in vivo and in vitro with the cytotoxic prodrug ganciclovir (GCV) 10 . We cultured organotypic cerebellar slices from 10-d-old CD11b-HSVTK mice with GCV (5 mg ml -1 ). After 14 d, GCV led to an almost complete loss of cells positive for IB 4 and CD68 (two macrophagespecific markers) in CD11b-HSVTK + (tk + ) slices (Fig. 4a,b) . The few remaining IB 4 + cells appeared fragmented or associated with IB 4 + blood vessels (Fig. 4a) . Time-lapse microscopy showed that microglial cells underwent apoptotic cell death (Supplementary Video 1 online). Neighboring microglia took up the dying cells but eventually also underwent apoptosis and were removed by other microglia. We quantified microglial depletion from images acquired by confocal laser scanning microscopy at a depth of 35-40 mm (that is, underneath the glial scar). Tk + slices showed reductions in microglia of 97%, 98% and 99% after 14, 28, and 42 d of GCV treatment, respectively (ANOVA, P o 0.001, n ¼ 4; Fig. 4c ). Few if any microglia were found outside the tissue in treated tk + slices (Fig. 4d) . Quantification of mRNA by quantitative RT-PCR showed a 98% reduction in CD11b transcript expression in tk + slices treated with GCV for 14 d (P o 0.001, n ¼ 3), whereas GFAP, MBP and neurofilament heavy-chain transcripts (markers for astrocytes, oligodendrocytes and neurons, respectively) were unaffected (ANOVA, P 4 0.05) (Fig. 4e) . Note that GCV treatment had no effect on tk -slices (Fig. 4e) . GFAP protein expression increased over time, and isoforms of lower molecular masses could be observed after 7-21 d in culture (Fig. 4f) . Depletion of microglia did not affect GFAP expression, suggesting that the astrogliosis induced by preparing and culturing the slices was independent of microglia activation. The concentration of PrP C was unaltered in microglia-depleted slices (Fig. 4g) .
Lack of 'bystander killing' after microglia depletion Phosphorylated GCV released from dying microglia may cause bystander toxicity. Thus we assessed the viability of CD11b-HSVTK + slices treated with GCV for 14 d with respect to PI incorporation and DEVDase activity. Microglia-depleted slice cultures showed a small but significant increase in PI + cells from approximately 1% (Fig. 4h) . We observed no difference in caspase activity (n ¼ 3 pools of four slices) (Fig. 4h) .
To evaluate whether the increase in cell death was due to impaired corpse removal, we reconstituted microglia-depleted slices with peritoneal wild-type macrophages resistant to GCV. Macrophages were placed either directly onto the slices or separated by Millicell-CM membranes. Direct reconstitution of slices with wild-type macrophages placed onto slices partially reduced the GCV-induced increase in PI + cells, suggesting a lack of removal of dead cells within Fig. 6 online) . We speculated that the increased PI + cells might represent dying or dead tk + microglia. To test this, we performed dual labeling of unfixed, GCVtreated CD11b-HSVTK slices with PI and IB 4 . In GCV-treated slices, most PI + cells also stained with IB 4 , indicating that the increase in PI + cells was indeed due to dead microglia (Fig. 4i,j) .
microglia-depleted tissue (Supplementary
Phosphorylated GCV released from dying cells can also cause cell cycle arrest 17 . We therefore assayed bromodeoxyuridine (BrdU) incorporation into the DNA of dividing cells. GCV treatment of tk + slices for 14 d abolished BrdU + CD68 + cells, as expected, whereas it did not affect the number of BrdU + CD68 -cells (non-microglial BrdU + cells characterized by a large nucleus) (Fig. 4k,l) . Also, GCV treatment of tk -slices had no significant effect on BrdU incorporation. Therefore, depletion of CD68 + cells was selective and transgene-dependent, and did not elicit any significant bystander effects.
Microglial depletion enhances prion replication
To address the contribution of microglia to prion replication, we prepared slices from tga20 TK CD11b-HSVTK -(tga20 TK-) and tga20 TK CD11b-HSVTK + pups (tga20 TK+ ). Tga20 TK+ and tga20 TK-slices infected with RML (100 mg RML, or 2.7 log SCI 50 ) were split into two pools, one of which was treated with GCV. After 30 d, similar amounts of PrP Sc were observed in untreated tga20 TK+ and in both untreated and GCV-treated tga20 TK-slices. Notably, microglial depletion by GCV treatment of tga20 TK+ slices resulted in a fivefold increase in PK-resistant PrP Sc (Fig. 5a ). As this increase was independent of PrP C expression ( Supplementary Fig. 7a online) , microglia either directly affected the conversion of PrP C into PrP Sc or, more likely, affected the half-life of PrP Sc by phagocytosing and degrading prions. To test whether the observed increase in PrP Sc was associated only with microglial expression of HSVTK, we infected slices prepared from 10-d-old GFAP-HSVTK mice allowing for conditional ablation of astrocytes 18 . In contrast to GCV treatment of CD11b-HSVTK + cultures, GCV treatment of GFAP-HSVTK + cultures had no major impact on PrP Sc or PrP C (Fig. 5b and Supplementary Fig. 7b ). Hence, increased PrP Sc levels were selectively associated with microglial depletion.
To further study whether the observed effect was due to GCVmediated removal of microglia, we tested whether the enhanced GCV PK: (Fig. 5c) . This increase in PrP Sc could be reduced upon reconstitution of slices with macrophages, irrespective of whether the macrophages expressed PrP C (Fig. 5c) . PrP C amounts were equal in all samples (Fig. 5d) . We verified microglial depletion and reconstitution by analyzing the expression levels of the macrophage marker Iba1 (Fig. 5e) . We observed no differences in GFAP expression (Fig. 5f ) or caspase activity (Fig. 5g) in either of the prion-infected tissues. Next, we used SCEPA to analyze tga20 TK+ samples, untreated or treated with GCV for 30 d, from three independent biological experiments performed on different days. Microglia-depleted cultures showed a significant 14.5 ± 13.2 fold increase over undepleted cultures in their prion titers (one-tailed paired Student's t-test, P ¼ 0.0474, n ¼ 3; Fig. 5h ), which corresponded very well to the difference observed by western blot analysis of microglia-depleted samples (9 ± 11.8 fold over that in undepleted slices, n ¼ 6). Despite a high interexperimental variance, all six independent replicas showed a clear increase in PrP Sc accumulation after microglial depletion (2-33 fold). No residual inoculum was observed in Prnp o/o -tk + culture, irrespective of microglia status (Fig. 5h) . These results confirmed that microglia negatively regulated both PrP Sc and prion formation.
T E C H N I C A L R E P O R T
Microglia-depleted tissue accumulated prions to a higher degree, begetting the question of whether GCV-treated tk + slices would be more sensitive to a prion infection. We therefore performed an endpoint titration experiment with RML on tga20 TK+ slices. Tga20 TK+ slices were infected with various concentrations of RML and separated into two pools, one of which was treated with GCV. After 5 weeks in vitro, we observed PK-resistant material in microglia-depleted tissue at a tenfold higher RML dilution. Hence, depletion of microglia rendered slices more sensitive to prion infections by 1 log (Fig. 5i and Supplementary Fig. 7c ).
DISCUSSION
Analytical sensitivity of POSCA, SCEPA and other methods As no certainty yet exists about the physical nature of the agent, transmission of serially diluted samples to susceptible hosts remains the gold standard for measuring prions. The POSCA strives to combine the versatility of the mouse bioassay, which can identify many strains of prions and take advantage of a large transgenic mouse repository, with the speed and precision of the SCEPA 4 . We evaluated the analytical sensitivity of the POSCA against the SCEPA 4 and the mouse endpoint bioassay 19 . The sensitivity of SCEPA was o10-fold higher than that of POSCA, the limits of detection being 7.7 log ID 50 per gram of brain for SCEPA, 9.9 log ID 50 g -1 for the tga20 bioassay and 46.7 log ID 50 g -1 for POSCA. Depletion of microglia led to a tenfold increase in analytical sensitivity, thereby approaching that of the SCEPA. As organotypic mouse slice cultures can be viable in culture for up to 26 weeks 20 , sensitivity might be enhanced by harvesting slices at later time points or by optimizing the infection and washing steps, particularly because residual inoculum does not seem to interfere with POSCA readings.
Only few cell lines, highly selective in their permissivity to various prion strains, are efficiently and chronically infectible with prions, and the crucial determinants of infectibility are unknown. In contrast, the transgenic expression of xenogeneic Prnp minigenes from various species has substantially broadened the range of strains measurable by mouse bioassay. The POSCA can fully exploit this broad range of hosts, as organotypic brain slice cultures can be prepared from mice of any desired genotype. This yields a fast, flexible and robust experimental system to study prion infection and the molecular basis of strain adaptation 21 in a highly controlled environment. Toward this goal, we have successfully infected POSCA slices with POSCA-derived inoculum (data not shown). We found that not only the chronically mouse-adapted RML prions but also a variety of sheep scrapie and bovine BSE strains replicate in slices derived from tga20 +/+ pups. The collection of POSCA-compatible strains includes ME7 prions, which do not replicate in PK1 cells 4 .
Compared to its in vivo counterparts, the POSCA has a very short incubation time. Intracerebral inoculation of tga20 mice with RML prions induces disease only after 60-150 d (ref. 22 ), yet we detected prion replication after 20 d in tga20 TK slices. Analogously, we observed prion replication in Prnp +/o slices after 35 d, whereas Prnp +/o mice show incubation times of 225-300 d after intracerebral inoculation 2 . The rapid replication in slices indicates that there may be unidentified protective processes that operate in vivo but may be disabled in slices.
Unexpectedly, we did not observe any pathological changes in POSCA slices as a consequence of prion infection. Although neuronal death and astrogliosis are among the defining morphological characteristics of prion-infected brains, we saw no significant changes in slice viability and in GFAP expression. It is unlikely that any developing pathology was masked by continuous removal of dead cells by microglia, because there was no difference between microglia-depleted and undepleted prion-infected slices. It is more likely that gliosis induced by tissue preparation may mask any further prion-induced pathology. Inasmuch as the relevant neuroectodermal cell types are preserved, we do not view these changes as limiting for the deployment of the POSCA.
Microglia in prion disease
Microglia activation is an early hallmark of prion diseases. Many studies point to potentially deleterious effects of microglia. First, microglia can release inflammatory and neurotoxic factors associated with neurodegenerative diseases [23] [24] [25] . Second, microglial cells are often spatially associated with prion plaques, and infectivity was recovered from microglia purified from terminally ill mice 6, 8, 26 , leading to the conjecture that microglia act as a carrier of prions within the brain. This scheme predicts that microglia might be detrimental at several levels, but cannot be easily reconciled with the observation that peripheral macrophages can reduce prion infectivity in vitro and splenic PrP Sc accumulation in vivo [27] [28] [29] . In addition, Prnp +/+ microglia do not support prion replication when grafted into Prnp o/o brains 30 .
Selective manipulation of microglial cells in vivo is hampered by their similarities to macrophages. In contrast, the POSCA is well suited to studying the impact of microglial manipulations on prion replication. We found that microglia could be completely ablated by treating CD11b-HSVTK + cerebellar slice cultures 10 with GCV without affecting the viability of other cell populations. Microglial removal drastically unleashed prion replication in organotypic slices, suggesting a role for microglia in containment of prion infections. Microglia may exert this effect by phagocytosing and degrading prions in situ [27] [28] [29] [30] , possibly explaining the presence of prions in microglia acutely isolated from mice sick with scrapie 26 , despite the inability of microglia to replicate prions 30 .
The above phenomena may have practical ramifications. One intracerebral ID 50 unit of prions has been reported to be equivalent to 10 4 -10 5 PrP molecules 31 . This is in contrast to many viral diseases, in which 1-10 particles are equivalent to one ID 50 , and has been taken to question the identity of the prion with PrP Sc (ref. 32) . The priolytic activity of microglia uncovered here may contribute to increasing the minimal amount of PrP Sc needed to infect individual organisms. By extension, one might speculate that medical conditions and iatrogenic interventions affecting microglia may heighten the susceptibility to prion infections.
METHODS
Culture preparation and prion inoculation. All mouse experiments conformed to Swiss law. The pups used for most experiments were F 1 offspring of tga20 +/+ Prnp o/o males on a 129Sv/BL6 background crossed to heterozygous CD11b-HSVTK females (tg620) on a C57BL/6 background 10 . We refer to the Prnp +/o tga20 + HSVTK transgene-negative offspring as tga20 TK-and the transgene-positive littermates as tga20 TK+ . Prnp o/o , Prnp +/o and Prnp o/o tga20 + mice were all on a 129Sv/BL6 background. CD11b-HSVTK (tg620) and GFAP-HSVTK mice (line 7.1) were all on a C57BL/6 background and were genotyped as previously described 10, 33 . Rocky Mountain Laboratory strain passage 6 (RML) was amplified in CD1 mice, ME7 in 129/Sv mice, 5193/1 in tga20 mice and 22F, 79A, 87A, 87V, 139V, 301V, 5192/2 and 301C (mouse-adapted BSE) were all amplified in C57BL/6 mice by intracerebral inoculation of 30 ml 10% wt/vol brain homogenate.
We prepared organotypic cerebellar slice cultures according to a modified version of a published protocol 34 . We obtained cerebella from 9-to 12-d-old pups. Brain tissue was embedded in 5 ml liquid (2% wt/vol) ultralow-meltingpoint agarose dissolved in Gey's balanced salt solution (GBSS) (NaCl 8 g l -1 , KCl 0.37 g l -1 , Na 2 HPO 4 0.12 g l -1 , CaCl 2 Á2H 2 O 0.22 g l -1 , KH 2 PO 4 0.09 g l -1 , MgSO 4 Á7H 2 O 0.07 g l -1 , MgCl 2 Á6H 2 O 0.210 g l -1 , NaHCO 3 0.227 g l -1 ) supplemented with the glutamate receptor antagonist kynurenic acid (1 mM) (GBSSK). We transferred liquid agarose (kept at 37 1C using a water bath) to a small container, submerged the isolated brain tissue and cooled on ice until the agarose solidified (10 min). The agarose block was mounted onto a specimen disc, and 350-mm-thick slices were cut on a vibratome (VT1000, Leica) while submerged in a cooled reservoir (4 1C) containing GBSSK. We recovered slices from the agarose and transferred them in a small volume of liquid to a 24-well plate using the broad end of a Pasteur pipette. Cultures were treated with various concentrations of prion-infected or uninfected brain homogenates (homogenized in PBS) diluted in 1 ml GBSSK. Tissues were incubated with brain homogenates as free-floating sections for 1 h at 4 1C and washed twice by transfer (in B0.5 ml) to a reservoir containing 6 ml fresh GBSSK. Five to ten slices were placed on a 6-well Millicell-CM Biopore PTFE membrane insert (Millipore). Residual GBSS was removed and the inserts were transferred to a cell culture plate and cultured in slice culture medium (50% vol/vol MEM, 25% vol/vol basal medium Eagle and 25% vol/vol horse serum supplemented with 0.65% glucose (wt/vol), penicillin/streptomycin and Glutamax (Invitrogen). Cultures were kept in a standard cell incubator (37 1C, 5% CO 2 and 95% humidity) and all of the culture medium was exchanged three times a week.
For reconstitution experiments, we obtained peritoneal macrophages by lavage. We killed mice and removed the abdominal skin without disturbing the peritoneal cavity, then injected 5 ml ice-cold PBS into the peritoneal cavity using a 25-gauge needle. After massaging the abdomen, we recovered macrophages and determined cells densities using 0.4% trypan blue. Slices were reconstituted at the time of preparation at a density of 250,000 macrophages per insert (ten slices per 6-well insert) and GCV treatment was initiated immediately. GCV was used at a concentration of 5 mg ml -1 , a concentration previously shown to be optimal for microglia depletion in vitro 10 .
Western blot analyses. We washed cultures twice in PBS, removed residual PBS and scraped the tissue off the membrane using 10 ml lysis buffer per slice (0.5% wt/vol sodium deoxycholate and 0.5% vol/vol Nonidet P-40 in PBS). Tissue was lysed by three freeze-thaw cycles and triturated using a 200 ml pipette until homogeneous. For vol/vol SCEPA analysis, we harvested slices by scraping tissue off the membrane in PBS, triturated using a 29-gauge insulin syringe and sonicated for 30 s. Each sample was a pool of 5-10 slices grown on the same insert, yielding approximately 200-350 mg protein in total. We determined protein concentration using the bicinchoninic acid assay (Pierce) and digested the tissue with PK (Roche) in lysis buffer for 30 min at 37 1C. PK-resistant material was detected as a standard by digesting 20 mg protein lysate in a reaction volume of 20 ml (1 mg ml -1 total protein) with 25 mg ml -1 PK. This condition allowed specific detection of PrP Sc . PK digestion was stopped by adding loading buffer (NuPAGE, Invitrogen) and boiling the samples at 95 1C for 5 min. Proteins were separated on a 12% Bis-Tris polyacrylamide gel (NuPAGE, Invitrogen) and blotted onto a nitrocellulose membrane. Membranes were blocked with 5% wt/vol Topblock (Fluka) in Tris-buffered saline supplemented with Tween (150 mM NaCl, 10 mM Tris HCl, 0.05% Tween 20 (vol/ vol)) and incubated with primary antibodies in 1% Topblock. Primary antibodies used were POM1 mouse IgG 1 antibody to PrP C (anti-PrP C ) (200 ng ml -1 ), ascites fluid of mouse anti-glial fibrillary acidic protein (GFAP) IgG 1 (clone GA5) (1:3,000, Sigma-Aldrich) and goat anti-human Iba1 (0.5 mg ml -1 , Wako). Secondary antibodies used were horseradish peroxidase (HRP)-conjugated rabbit anti-mouse IgG 1 (1:10,000, Zymed) and HRP-conjugated swine anti-rabbit IgG (260 ng ml -1 , DAKO). The blots were developed using SuperSignal West Pico chemiluminescent substrate (Pierce) and detected using the VersaDoc system (model 3000, Bio-Rad). The molecular weight marker was spiked with recombinant PrP C , yielding a PrP signal at 23 kDa with a cleavage product at 15 kDa. We loaded 10 ml marker in the left lane on all blots.
Cell death measurements. We measured PI incorporation by incubating the slices with propidium iodide (10 mg ml -1 , Molecular Probes) for 15 min. Images were acquired using a fluorescent microscope (Axiovert 200M equipped with Axiocam HRm, Zeiss) and analyzed using image analysis software analySIS vs5.0 (Olympus Soft Imaging Solutions GmbH). All images were acquired using the same exposure times and analyzed using the same software settings within a region of interest (the total area of tissue present in the image). After recording fluorescence images, we washed the tissue in PBS and lysed it in PBS containing 0.5% vol/vol Nonidet P-40, 0.5% wt/vol sodium deoxycholate and 5 mM 1,4-dithiothreitol. We used a caspase-3 fluorometric correlate assay (Assay Designs) to determine caspase-3 DEVDase activity: protein lysates were incubated with the fluorogenic caspase-3 substrate acetyl-Asp-Glu-Val-Asp-7-amino-4-methyl-coumarin, and enzymatic cleavage by caspase-3 was quantified by kinetic measurements (one measurement every 2 min for 2 h) using a fluorometer. The specific caspase activity was calculated from a standard curve generated using recombinant caspase-3 with a known enzymatic activity and normalized to the protein content. One unit of caspase-3 activity is defined as the amount of enzyme needed to convert 1 pmol of substrate per minute at 30 1C.
Immunocytochemistry. We performed histoblot analysis according to a standard protocol using 50 mg ml -1 PK (30 min, 37 1C) 15 . Proteins were transferred from slice cultures to nitrocellulose membranes by pressing the tissue onto membranes soaked in lysis buffer. After protein transfer, membranes were digested with PK and PrP Sc was detected with POM1. For immunocytochemistry, the tissue was fixed in 2% wt/vol PFA overnight at 4 1C. Membrane inserts were washed and incubated for 1 h in blocking buffer (0.1% vol/vol Triton X-100 and 2% vol/vol goat serum dissolved in PBS) and incubated for 2 d with primary antibody diluted in blocking buffer. Primary antibodies and concentrations used were ascites fluid of anti-chicken calbindin IgG 1 antibody (1:2,000, Swant), rabbit anti-mouse GFAP polyclonal antibody (1:1,000, DAKO), rat anti-mouse CD68 IgG 2a (1 mg ml -1 , Serotec) and ascites fluid of rat anti-bovine MBP IgG 2a (1:250, Serotec). The primary antibodies were detected using Alexa-conjugated secondary antibodies (4 mg ml -1 , Molecular Probes) and counterstained with 4,6-diamidino-2-phenylindole (DAPI) (1 mg ml -1 ). Microglia were detected in fixed and in live tissue by staining with IB 4 (Griffonia simplicifolia) (2-4 mg ml -1 , Molecular Probes). We removed the culture membranes from the inserts and mounted them directly onto a microscope slide using fluorescence mounting medium (DAKO). Images were acquired in a focal plane 35-40 mm below the tissue surface using a laser-scanning confocal microscope (SP 2, Leica), by fluorescence microscopy (Axiovert 200M, Zeiss) or, for live imaging studies, by using wide-field microscope (DM IRBE, Leica) equipped with a temperature controller and a CO 2 box (37 1C, 5% CO 2 ). We assessed incorporation of 5-BrdU into the tissue after 24 h incubation with 25 mg ml -1 BrdU. DNA was denatured by treatment with 1M HCl for 1 h at 37 1C, followed by two 30-min neutralization steps with 0.1 M borate, pH 8.5, and two washes in PBS. We then stained the tissue with 15 mg ml -1 mouse IgG 1 anti-BrdU (clone BU-33, Sigma) and rat anti-mouse CD68 according to normal procedures. We counted cells manually, assisted by image analysis software analySIS vs5.0.
Quantitative PCR. Organotypic slice cultures were prepared and incubated as previously stated. We washed cultures once with PBS and extracted total RNA using TRIzol reagent (Invitrogen Life Technologies) according to the manufacturer's protocol. Before cDNA synthesis, residual genomic DNA was removed using the DNA-free kit (Ambion); cDNA was synthesized from 1 mg total RNA with the QuantiTect reverse transcription kit (Qiagen) using random hexamers according to the manufacturer's protocol. We tested for successful cDNA synthesis (+ reverse transcriptase) and contamination of total RNA with genomic DNA (À reverse transcriptase) by PCR with primers specific for b-actin (Actb). Quantitative real-time PCR was performed using the SYBR Green PCR Master Mix (Applied Biosystems) on an ABI PRISM 7700 Sequence Detector (PerkinElmer). Regulation was calculated relative to untreated wildtype slices after normalization to the Actb signal. The following primer pairs were used: Actb sense (NM_007393), 5¢-GACGGCCAGGTCATCACTAT-3¢; antisense, 5¢-ACATCTGCTGGAAGGTGGAC-3¢. Itgam sense (NM_008401), 5¢-GACTCAGTGAGCCCCATCAT-3¢; antisense, 5¢-AGATCGTCTTGGCAGAT GCT-3¢. Gfap sense (P03995), 5¢-AAGGGACCATTCCCTGTC-3¢; antisense, 5¢-AGGTTAGCGGAGGTGGAA-3¢. Mbp (NM_010777) and Nefh (NM_010904) we detected using the commercially available QuantiTect primer assay (Qiagen).
Scrapie cell assay in endpoint format (SCEPA) Prion-susceptible neuroblastoma cells (subclone N2aPK1) were exposed to 300-ml brain homogenates in 96-well plates for 3 d. Cells were subsequently split three times 1:3 every 2 d, and three times 1:10 every 3 d. After they reached confluence, we filtered 25,000 cells from each well onto the membrane of an ELISPOT plate, treated them with PK (0.5 mg ml -1 for 90 min. at 37 1C), denatured, and detected individual infected (PrP Sc -positive) cells by immunocytochemistry using alkaline phosphataseconjugated POM1 mouse anti-PrP and an alkaline phosphatase-conjugated substrate kit (Bio-Rad). We performed serial tenfold dilutions in cell culture medium containing healthy mouse brain homogenate. Scrapie-susceptible PK1 cells were then exposed to dilutions of experimental samples ranging from 10 À3 to 10 À6 , or to a 10 À3 dilution of healthy mouse brain homogenate or RML. Samples were quantified by total luminescence per well or, in endpoint format, by counting positive wells according to established methods 4 .
Statistical analysis We used one-way ANOVA with Bonferroni post-test for selected pairs of columns for statistical analysis of experiments involving the comparison of three or more samples, and paired Student's t-test for comparing two samples. Results are displayed as the average of replicas ± s.d. For assay comparisons in Table 1 , all values are given as the determined titer ± the standard error calculated within each single experiment (that is, reflecting technical rather than biological variations).
Note: Supplementary information is available on the Nature Neuroscience website.
